πŸ‡ΊπŸ‡Έ FDA
Patent

US 7442790

Caspase inhibitors and uses thereof

granted A61KA61K31/4015A61K31/403

Quick answer

US patent 7442790 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4015, A61K31/403, A61K31/407, A61K31/435